Biosimilars In Limelight On FDA Approval Of Amgen Drug
September 27, 2016 at 13:30 PM EDT
Late last week, the FDA approved yet another biosimilar product -- biotech giant Amgen Inc.’s Amjevita (adalimumab-atto).
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.